Inpharma Weekly

, Volume 1496, Issue 1, pp 7–7 | Cite as

Galiximab promising for relapsed or refractory follicular lymphoma

Clinical study
  • 4 Downloads

Keywords

Lymphoma Median Time Stable Disease Progressive Disease Clinical Oncology 

Copyright information

© Adis International Ltd 2005

Personalised recommendations